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Depression is estimated to affect 350 million people worldwide and is the leading
cause of disability (WHO, 2012). According to the Center for Disease Control (CDC) 8%
of the U.S. population age 12 years or older report current depressive symptoms, while
approximately 8 million ambulatory care visits result in the diagnosis of major depressive
disorder per year (Centers for Disease Control, 2011; Centers for Disease Control, 2012).
Twice annually, college students are asked to complete a college health assessment by The
American College Health Association (ACHA). Each year this health assessment provides
a startling look at the mental health status of American college students. In the spring of
2013, ACHA released the results showing 45% (n= 55,385) of college students stated they
“felt things were hopeless”, 31.3% (n=38,523) “felt so depressed it was difficult to
function”, while 7.4% (n=9,107) had seriously considered suicide, and 1.5% (n=1,846) had
attempted suicide in the preceding 12 months.
Screening for depression in primary care has been supported by the World Health
Organization, the U.S. Preventive Services Task Force, and the American Academy of
Family Physicians (AAFP). The AAFP and U.S. Preventive Services Task Force both
recommend clinics with the capability to treat depression should screen adults 18 years and
older at every visit. The Institute for Clinical Systems Improvement developed a guideline
titled Adult Depression in Primary Care (Mitchell et al., 2013) to assist providers in the
assessment, diagnosis, and treatment of depression.
Despite these statistics and guidelines, many providers struggle to implement
depression screening. The purpose of this practice inquiry project was to evaluate potential
changes in provider’s documentation of depression screening after implementing a provider
education session and the use of a depression screening tool. This practice inquiry project
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consists of three manuscripts each of which provide further insight for the implementation
of a depression screening program.


Manuscript one is an integrative review of literature that assisted in providing the
foundation for this project. The integrative review focused on reported barriers to
the implementation of depression screening programs, depression screening tools,
and published reports of successful integration of depression screening.



Manuscript two is a review of the guideline Adult Depression in Primary Care
(Mitchell et al., 2013). This guideline provided guidance in the creation of the
depression screening program implemented in this practice inquiry project.



Manuscript three describes the development, implementation, and evaluation of a
depression screening program at a large university student health clinic.

8

Manuscript 1

Implementation of Depression Screening in the Primary Care Setting:
An Integrative Review
Mary Kate Stafford
University of Kentucky
College of Nursing
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Implementation of Depression Screening in the Primary Care setting: An Integrative
Review
According to the Center for Disease Control, approximately 25 million
Americans, age 12 years or older report current depression (2012), and in 2009-2010
eight million ambulatory care visits resulted in the primary diagnosis of major depressive
disorder (2013). With the vast number of patients experiencing depression and
depressive symptoms, depression screening rates are astoundingly low with only 2.2% of
primary care office visits having depression screening documented as performed. In an
attempt to improve these rates, Healthy People 2020 objective MDMD 11.1 calls for an
increase in the percentage of primary care providers who screen patients for depression
during office visits from 2.2% to 2.4% (2012).
Depressive symptoms have the ability to interfere with all aspects of a person’s
life including interpersonal relationships, physical health, and having a functioning role
in society. As a society, the burden of depression is experienced through the cost of
someone’s life, decreased work productivity, and increased cost of medical care (U.S.
Preventive Services Task Force, 2009). The recommendation for depression screening in
primary care has been supported by the World Health Organization (WHO), the U.S.
Preventive Services Task Force (USPSTF), and the American Academy of Family
Physicians (AAFP) (WHO, 2013; USPSTF, 2015; & AAFP, 2012). AAFP’s guideline,
Screening for Depression, recommends providers screen for depression in adult
populations when staff-assisted depression care supports are in place (2012). The
AAFP’s guideline for depression screening coincides with the recommendation of the
U.S. Preventive Task Force that adults should be screened for depression in practices that
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have the ability to correctly diagnose, effectively treat, and provide follow-up care
(2002).
Despite these recommendations, many providers struggle to implement
depression screening due to the multitude of factors that serve as barriers to depression
screening. Barriers to depression screening include limited appointment time to screen
and address other chief complaints, lower priority during the appointment, limited
resources within office to screen, limited community resources to treat and follow-up on
positive screens, and potential limited knowledge regarding screening recommendations
and screening tools. Therefore, the focus of this literature review is to understand
potential barriers to and suggestions for the implementation of a successful depression
screening program.
Methods
Before implementing a screening program, it is imperative to review the literature
for other programs that have been both successful and found areas for growth. This
author attempted to find programs that addressed and attempted to overcome common
barriers to depression screening. Previous research has shown barriers to depression
screening to include the following: lack of knowledge regarding current guidelines, lack
of providers’ confidence in screening and treating depression, lack of resources to
diagnosis, treat, and manage depression, and the providers’ limited time with a patient
(Machado & Tomlinson, 2011).
To assist with the literature search, the following PICOT question was
formulated: In primary care patients 18 years or older, what are the barriers to depression
screening? A search of the literature was conducted using CINAHL, Cochrane Library,
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PubMed, and MedLine. The following terms were used while performing the search:
depression, screening, program, project, primary care, implementation, nurse practitioner,
and family physician. Based on the search terms, the original search yielded 225 articles.
Using inclusion and exclusion criteria, seven articles were selected to be included in this
review. The inclusion criteria for this review included: English language, peer-reviewed
journal, participants 18 years or older, depression screening, and the primary care setting.
Studies that were excluded included those containing a non-English language, patient
populations with co-morbid conditions, depression interventions other than screening,
patient populations with children and adolescents, and settings other than primary care
were excluded from this review.
To analyze the literature, the strength of recommendation taxonomy (SORT)
method was utilized to provide the literature grades from levels one to three (Ebell et al.,
2004). Within the SORT method (see Table 1), level one is assigned to good-quality,
patient-centered evidence presented through randomized-control trials. A level two
distinction is given to limited-quality patient-centered evidence and includes systematic
reviews and meta-analyses. Lastly, a level three distinction is given to other evidence
presented through guidelines, general practice, expert opinion, or case studies (Ebell et
al., 2004).
Findings
The initial literature search returned many studies related to depression, however
only two provided synthesis of current evidence to support or negate the use of routine
depression screening, while the remaining five articles addressed barriers related to
depression screening. A systematic review (level I in SORT methodology) conducted by
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Gilbody, House, and Sheldon (2009) was performed reviewing 12 studies with the
purpose of evaluating the effectiveness of depression screening in improving the
recognition and management of depression. Of the 12 studies, nine were performed in
the primary care setting, two in a general outpatient setting, and one in an elderly
inpatient setting. The patients within these nine studies fell within two populations: 1)
patients were included regardless of their baseline screening score or probability of
having depression and 2) a high-risk population where patients were only included and
randomized if they scored above certain scores on the depression screening tool. The
intervention groups consisted of reporting the depression screening scores to the
providers versus the control groups where depression screening scores were not reported
to the healthcare provider.
Nine of the studies included in this systematic review addressed the potential
effects of screening on the recognition of depression (Gilbody, House, & Sheldon, 2009).
Overall, the studies showed a very slight positive increase on depression recognition with
the use of a depression screening tool with a relative risk of 1.38 (95 % confidence
interval 1.78 to 3.96). A more significantly positive increase was shown in three studies
that only used high risk populations with patients scoring higher on the depression
screening tools (relative risk 2.66, 95% confidence interval 1.78-3.96). This effect was
lessened by the six studies that utilized the unselected feedback patient populations,
which provided no improvement in the recognition of depression recognition (relative
risk 1.00, 95% confidence interval 0.89-1.13).
Gilbody, House, & Sheldon (2009) also reviewed the effects of screening on the
management of depression, with eight of the 12 studies addressing this objective. The
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authors included any documented intervention as a positive outcome for the management
of depression. Although overall the studies provided a slightly higher intervention rate
(relative risk 1.35, 95% confidence interval 0.98 to 1.85) in the studies utilizing a
depression screening tool, these results were primarily due to two studies using the high
risk patient populations versus the patient populations including all patients screened
regardless of risk. Lastly, using four of the 12 studies the authors addressed the potential
effects of depression screening on long-term outcomes of depression finding no
significant improvement at zero to six months or at a 12 month follow-up.
In comparison to the above systematic review, O’Connor, Whitlock, Gaynes, and
Beil (2009) conducted a systematic review (level I evidence) with the primary objective
of reviewing updated evidence regarding the Agency for Health Care Research and
Quality’s B grading supporting depression screening in primary care. This systematic
review served as an update of literature following the 2002 systematic review conducted
by Pignone, et al., which served as the original foundation supporting the
recommendation. The authors asked key questions to guide their research specifically
focusing on if screening for depression would reduce morbidity and mortality, and if any
potential harms related to depression screening had been documented. To evaluate
reduction of morbidity and mortality, only one study was found that specifically
attempted to compare a screened versus unscreened group. Within the screened group,
969 patients were randomly assigned and were screened prior to their appointment with
the provider, a non-screening group was also utilized in which the patients were not
screened prior to their appointment but were screened after to evaluate for depressive
symptoms. The authors found the depressed patients screened for depression were more
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likely to have recovered at 3 months (with less than 1 depressive symptom) compared to
the unscreened group. However, when combining the groups, the study lacked the
necessary power to apply their results to a broader population.
O’Connor, Whitlock, Gaynes, and Beil (2009) also attempted to address the
potential impact of provider response to screening results on the recovery from
depression by reviewing eight randomized control trials with varying screening and
levels of intervention strategies to address positive depression screens. Within the eight
studies, conflicting reports of potential reduction of depressive symptoms were given,
with the more significant impact reported in studies with greater availability of resources
for intervention. The authors deduced a potential decrease in depressive symptoms with
intervention resources available, yet the authors were unable to specifically identify the
effect of provider feedback related to depression screening scores. Regardless of the
mixed review, O’Connor, Whitlock, Gaynes, and Beil (2009) did not find reports of
potential harm in screening patients for depression, and the U.S. Preventive Services
Task Force used this review as part of the evidence to support depression screening in
primary care.
The remaining articles retrieved in the literature search addressed the multitude of
barriers to screening for depression in primary care that have been cited in the literature.
Although the major guidelines recommended screening, this recommendation is based on
the foundation that supports are in place to provide adequate diagnosis, treatment, and
follow-up for patients. One barrier that was hypothesized was lack of provider
knowledge regarding current guidelines. As demonstrated by the two systematic reviews,
conflicting data exists regarding support for depression screening. In an attempt to
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disseminate the recommendations from USPSTF, Richardson and Puskar (2012) provided
a brief overview of the recommendation to screen only when staff-supported resources
are in place (evidence level II). The authors reviewed seven potential screening tools
providers might utilize, with the majority of their focus on the PHQ-9, including its 81%
sensitivity and 92% specificity. As supported by USPSTF, the authors stressed the
importance of follow-up care with the patient.
To provide further confidence in screening recommendations, Roman and Callen
(2008) provided brief summaries of eight screening tools available for adults in primary
care. The authors sought to find instruments that were brief (to save the provider time
and keep from tiring an older adult patient) and were evidence-based. In harmony with
the USPTF recommendations, Roman and Callen (2008) stressed the need for a delivery
system to care for patients needing further evaluation and treatment of depression.
However, this summary of the literature functioned as a quick overview and would allow
a provider to quickly decide which tool may fit specific situations. Although this study
provided a review of the literature, it would be given the evidence rating of Level Three.
Staff-supported resources may include trained staff to provide screening, access to
screening tools, patient education materials, and the ability to follow-up and treat whether
it is the primary care provider or a mental health provider within the community.
Cashman, Hale, Candib, Nimiroski, and Brookings (2006) attempted to address the
barriers related to staffing resources as they studied the implementation of a pilot
depression screening program. Stating the USPTF’s recommendation for screening of
depression and a previously performed internal audit showing 33% of patients having a
diagnosis of depression, Cashman et al. (2006) developed a screening program.
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In the formative stages of this program, medical assistants and nurses were trained
to recognize the difference between depression and grief, as well as the use of the Center
for Epidemiologic Studies-Depression Screen (CES-D) (Cashman et al., 2006).
However, due to limited staff resources, the authors trialed the use of first-year graduate
nursing students (GSNs) to provide consistent depression screening. Providers picked
red-flag patients for which the GSNs provided the depression screening instead of
providing depression screening to all patients. In eight months of screening, 117 patients
(out of 207) responded positively to one of the two screening questions of the CES-D,
while 100 patients were diagnosed with depression. Of these 100 patients, 84% accepted
a form of treatment (cognitive therapy, pharmacologic, or watch and wait).
Although Cashman et al (2006) found the use of GSNs beneficial in providing
additional providers to screen patients, the use of students was not a reliable avenue for
fulfilling staffing shortages. The authors found other barriers in implementing their pilot
program which included: limited lime for screening, limited time for investigating other
risk factors, the need for interpreters, and issues with the information technology used.
Using the strength of recommendation taxonomy (see Table 1), Cashman et al. (2006)
study would be considered a Level Two, as this study is a non-randomized control trial.
Multiple authors have attempted to address the barrier of time necessary to
perform depression screening. Schmitt, Miller, Harrison, Touchet (2010) attempted to
address the barrier of time in regards to depression screening. The authors utilized data
from the National Ambulatory Medical Care Survey which included data regarding
patient visits within 17,463 physician offices. Of the patient visits 3.4% documented
depression screening and was associated with increased probability of having longer visit
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duration when compared to visits without depression screening. The authors explained
due to the increase in appointment time a lack of incentive exists for depression screening
for primary care providers. The lack of incentives include increased visit duration of 1 to
15 additional minutes (with the mean of 6 minutes added to the appointment), increased
cost due to staff and resources, and limited reimbursement. As seen in Table 2, this
qualitative study has an evidence level rating of two.
In a desire to meet current recommendations regarding screening and attempting
to be mindful of time, Farrell et al. (2009a) sought to decrease the amount of time
necessary for depression screening through the use of touch screen computer-based
technology. The authors performed initial depression screening in a rural, primary care
setting using the PHQ-9 questionnaire. The setting for this study was the University
Medical Associates (UMA) at the University of Virginia Primary Care Clinic. The
investigators first piloted a small study (9 participants) to critique the use of a touch
screen computer to facilitate depression screening. The authors found the participants
and medical providers were accepting of the electronic program, as long as it worked into
the flow of the clinic visit and was in a convenient location within the office.
The implementation of the screening program has been described in a second
article by Farrell et al. (2009b). After piloting the use of computer touch screens with
nine participants and receiving feedback, the authors attempted to implement the
screening program with a small convenience sample of 20 participants with the average
age of 44. Of these participants, 20% were found to have depression needing treatment,
while 25% needed further evaluation. The authors also reported the average time
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required for a patient to complete the electronic depression screening to have been less
than three minutes.
Gap Analysis
Thus far, the evidence has provided conflicting, minimal support for the
recommendations regarding depression screening. The two systematic reviews showed
only minimal decreases in mortality or morbidity, as well as minimal improvement in
overall depressive symptoms when comparing entire study samples. One downfall to the
studies discussed in both systematic reviews, is the potential for confounding variables
and the difficulty to truly extract positive impacts depression screening alone has on
overall mortality and morbidity. However, regardless of the minimal improvement, no
adverse effects of depression screening have been identified therefore allowing the
recommendations to continue to stand.
The literature does support the use of screening tools with a variety being tested
and validated in the primary care setting and the literature provides several consolidated
reviews (Richardson & Puskar, 2012; Roman & Callen, 2008). With the variety of
screening tools, the provider may be able to choose an appropriate tool for differing
situations for goodness of fit (Roman & Callen, 2008). It is beyond the scope of this
paper to individually review each screening tool and the tool’s potential in differing
settings.
It has been shown depression screening does increase the duration of office visits,
(Schmitt, Miller, Harrison, & Touchet, 2010). To overcome this particular barrier,
studies have been performed to look at the use of different technologies for screening,
such as the example of the use of computer-based screening tools in patients (Farrell et
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al., 2009). Further analysis of the literature could be performed specifically comparing
various screening methods such as the use of paper encounter forms, electronic sign-in,
and provider administered screening. Regardless of the tool used for depressions
screening, Cashman, et al. (2004) found an increased incidence of positive identifiers for
depression, therefore allowing for increased diagnostic screening, and treatment or
referral.
The literature provided by the systematic reviews focused on an all-encompassing
inclusion criteria of adults (18 years or older), with several focusing on specifically the
older adult. During the literature the author found little information on specifically the
young adult population ranging from 18 to 35 years old. Further research could be
conducted on this age group due to the many changes and new stressors this population
faces. These changes and stressors include college, beginning careers and families,
becoming independent from their parents, and changes in support groups.
Schmitt et al. (2010) suggest further research should be performed to analyze the
real-world application of depression screening. Few figures have been published
regarding the cost versus benefit of implementing a depression screening program in the
primary care setting. As mentioned above, Schmitt et al. (2010) also notes increased cost
and decreased reimbursement as a barrier.
Lastly, one limitation cited by both Gilbody, House, and Sheldon (2009) and
O’Connor, Whitlock, Gaynes, and Beil (2009) is that most studies regarding
implementation of depression screening programs have been small pilot studies, which
make the results more difficult to generalize to an entire population. With the current
guideline stating the need for screening of all patients but only in a system that has the
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support for referral, treatment, and follow-up; more effort needs to be applied in creating
and analyzing macrosystem changes related to depression screening.
Overall, the literature is lacking in its strength of evidence as discussed by
Gilbody, House, and Sheldon (2009) and O’Connor, Whitlock, Gaynes, and Beil (2009).
With several different depression screening tools, a variety of populations and settings,
and many ideas on how to implement, there is little consistency within the evidence.
Also lacking within the literature are descriptions of successful program implementation
larger than a small pilot study. Finally, the evidence providing cost analysis is minimal,
creating larger barrier to implementing depression screening programs.
Recommendations
Although the literature review focused on the many barriers to implementing a
depression screening program, the studies all recommended specific designs for the
implementation of a depression screening program. Richardson and Puskar (2012) and
Roman & Callen (2008) strived to educate providers regarding the current validated
depression screening tools available, including the general adult population and the older
adult population. Schmitt et al. (2010) recommended the use of the PHQ-9 screening tool
due to its specificity and sensitivity as well as its brevity. Cashman et al. (2004),
recommended the use of screening questions in the patient encounter form. The use of
the encounter form while the patient was waiting to be seen was thought to decrease the
time required for staff to screen and review the depression screening tool. Schmitt et al.
(2010) utilized computers to screen patients for depression, similar to the study of Farrell
et al. (2009).
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The implementation of a depression screening program is multifaceted and
requires the knowledge and research of many. Further studies are needed regarding
specific implementation strategies, those that are both successful and not as successful.
Lastly, cost analysis should be provided in future implementation programs. Cost
analyses would allow for future program planners to evaluate strategies to increase
incentives for primary care providers to perform depression screening for all adult
patients.
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Table 1. Grading Criteria Legend – SORT Method
Study Quality Diagnosis
Treatment/prevention/screening
Level 1:
Validated
SR/meta-analysis or RCTs with
Good
clinical decision consistent findings.
Quality,
rule SR/metaHigh quality individual RCT.
patientanalysis of high- All-or-none Study
oriented
quality studies.
evidence
High-quality
diagnostic
study.
Level 2:
Unvalidated
SR/meta-analysis of lower
limitedclinical decision quality clinical trials or of
quality
rule.
study with inconsistent findings
patientSR/metaLower quality clinical trial.
oriented
analysis of
Cohort study
evidence
lower quality
Case-control study
studies or
studies with
inconsistent
findings

Prognosis
SR/meta-analysis
of good quality
cohort studies.
Prospective
cohort study with
good follow-up.

SR/meta-analysis
of lower quality
cohort studies or
with inconsistent
results.
Retrospective
cohort study or
prospective
cohort study with
poor follow-up.
Case-control
study
Case series
Level 3: other Consensus guidelines, extrapolations from bench research, usual
evidence
practice, opinion, disease-oriented evidence (intermediate or
physiologic outcomes only), or case series for studies of diagnosis,
treatment, prevention, or screening).
Ebell, et al. (2004). Strength of recommendation taxonomy (SORT): a patient-centered
approach to grading evidence in the medical literature. American Family Physician,
69(3), pg. 548-556. Retrieved from: http://www.aafp.org/afp/2004/0201/p548.pdf
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Table 2. Summary Review of Articles
Depression Screening in the Primary Care Setting
Author & Year Type of
Sample
Purpose of
Literature
Article
Design
(Cashman, Hale, Non207
To evaluate
Candib,
randomize
Patients
the pilot
Nimiroski, &
d control
study of a
Brookings,
trial
117
depression
2004)
patients +
screening
for one or
and
both
treatment
questions
program.
Of the 117,
100 scored
positive for
depression

(Farrell et al.,
2009)

Gilbody, House,
& Sheldon,
2009)

Nonrandomize
d control
trail

Systematic
Review

20 person
convenienc
e sample

Twelve
studies
-9 in
primary
care
-2
outpatient
-1 elderly
inpatient
setting
Patient
screened
regardless
of risk
versus
high-risk
patients

Findings

Implications

Evidence
Level

Comments

Training
required for
medical
staff and
nurses.

Must address
challenges:
limited, time,
and staff.

Level 2

In the
conclusion,
decided the
2 questions
would have
been helpful
on the
encounter
form before
the patient is
seen.

Electronic
screening is
efficient and
accurate in
screening for
depression.

Level 2

Use of PHQ9

States limited
support for
depression
screening

Level 1

Cochrane
review
Limited
evidence to
support
screening

Initial use
of 2
question
screen
If +
completed
CES-D

To evaluate
the
implementa
tion of escreening
in a rural
population.

Effectivene
ss of use of
screening
tool on
detection
and
manageme
nt of
depression

Screened
small
number of
red flag”
patients
7 % of
participants
had no
depression.
25% mild,
20%
moderate,
10%
moderately
severe, 0%
severe
depression
Reported
easy use of
e-screening
Conflicting
data with
minimal
improveme
nt in
regards to
patients
risk for
depression
or provider
notification
.
Difficulty
differentiati
ng
screening
versus
interventio
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(O’Connor,
Whitlock,
Gaynes, & Beil,
2009)

Systematic
Review

Interventio
ns included
provider
notified or
not of
screening
score
1 RCT (n=
969)
addressing
screening
effects on
mortality
and
morbidity

n effect on
improved
screening
scores

To update
literature
related to
USPTF’s
statement
supporting
depression
screening

Minimal
improveme
nt on
mortality or
morbidity.

Educate
providers
on brief
depression
screening
and
assessment
methods.

To
education
providers
on 8
depression
screening
tools

8 RCTs
(n=1908)
addressing
clinical
feedback
and
remission
of
depression

(Richardson &
Puskar, 2012)

(Roman &
Callen, 2008)

Expert
Opinion

Expert
Opinion
and
Extrapolati
ons from
research.

Unknown
number
articles to
rule out
adverse
effects
related to
screening
N/A

N/A

Due to no
adverse effect
finding,
USPSTF
continues to
recommend
depression
screening
with staffsupported
resources in
place.

Level 1

Primary
focus on
staffsupported
resources.

PHQ-2 and
PHQ-9quick,
effective,
and tested
in primary
care
settings.

PHQ-9 may
be used to
tracking
outcomes.

Level 3

Barriers to
screeninglimited time,
uncertainty
regarding
tool, limited
follow-up
plan.

All are
appropriate
screening
tools for
depression:
Geriatric
Depression
Scale
(GDS),
GDS-15,
Center for
Epidemiolo
gic Studies
Depression
Scale
(CES-D),

Recognizing
symptoms is
first step in
preventing
suicide.

Level 3

N/A

Difficulty
in
generalizin
g
improveme
nt in
depressive
symptoms
related to
provider
feedback
due to
limited
power in
sample
size.
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All positive
screenings
require
diagnostic
interviewing
or referral.

Provider
treatment
plans, or
referral plans
must be
outlined.

(Schmitt, Miller,
Harrison, &
Touchet, 2010)

Qualitative
Study

14,736
physician
office
visits

To evaluate
the increase
in office
visit
duration
due to the
addition of
depression
screening.

CES-D
Short
Form,
Hamilton
Depression
Scale, Beck
Depression
inventory,
PHQ-9,
Cornell
Scale for
Depression
in
Dementia
Depression
screening
significantl
y increased
the
duration of
the office
visit.

Methods to
increase
efficiency and
decrease time
screening
must be
evaluated.
Different
technologies
to make
screening
easier are
needed- such
as
computerized
screening,
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Level 2

Must
continue to
assess
barriers:
must have
plan in place
to treat or
refer
patients
once
diagnosed.
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Guideline Analysis: Adult Depression in Primary Care
The National Institute of Mental Health (2011) defines depression as a serious
illness in which the symptoms interfere with all aspects of an individual’s life.
Individuals experiencing depression experience lack of interest in pleasurable things,
weight loss or gain, insomnia or excessive sleeping, fatigue, decreased ability to
concentrate, and thoughts of suicide (American Psychological Association, 2013).
Depression is estimated to affect 350 million people worldwide and is the leading cause
of disability (WHO, 2012). In the United States, approximately 1 in 10 people currently
experience depressive symptoms (CDC, 2012), and the cost of depression in the U.S. is
as high as $44 billion (CDC, 2013).
The ultimate cost of depression, is that of a person’s life. In 2004 the CDC
ranked suicide as the 11th leading cause of death (CDC, 2012). In 2007, Mental Health
America (MHA) reported rankings for each state and the District of Columbia regarding
their depression and suicide rates, and the overall mental health of each state. The overall
mental health of Kentucky was ranked by the MHA (2007) as 49 th (out of 51 states and
the District of Columbia). According to 2004-2005 data, 8.5% of Kentucky adults
suffered from a major depressive episode and suicide rates in Kentucky ranked 34th in the
country.
Depression is an important issue in Kentucky and the nation. Due to its high
importance national evidence-based guidelines and recommendations have been created
to support providers in the practice of screening for depression and to help guide
providers in correctly identifying depression. The purpose of this paper is to analyze the
guideline Adult Depression in Primary Care. The developing organization of this
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guideline was the Institute for Clinical Systems Improvement (ICSI). This guideline was
last revised in September 2013. The overall objective of this guideline was to inform
providers about effective assessment, diagnosis, and treatments of adults diagnosed with
depression, as well as increase the percentage of patients accurately diagnosed with
depression (Mitchell et al., 2013).
Stakeholder Involvement
The ICSI is a nonprofit organization sponsored by five Minnesota and Wisconsin
non-profit health plans. When developing guidelines ICSI utilizes a multidisciplinary
work group of medical professionals. To develop guidelines, work groups are created
with 6-12 individuals who are knowledgeable about the topic. The work group for this
particular guideline included physicians, pharmacists, psychologists, psychiatrists, and
nurse practitioners (Mitchell et al., 2013). In the interest of full disclosure the individual
organizational affiliations of each group member were provided. However, many
national organizations such as the American Psychological Association or the American
Academy of Family Physicians were not named, although these individuals may be
members of larger organizations. Also credentials for each work member were provided
but lacked explanation of specific experience related to caring for patients with
depression.
Rigor of Development
To evaluate the evidence to inform the guideline development, a literature search
was divided into two phases: the first stage identified systemic reviews, while the second
phase identified randomized control trials, meta-analyses, and other literature (Mitchell et
al., 2013). The authors did not list which databases were utilized for this literature
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search. At the completion of the literature search the work group ranked the evidence.
ICSI utilized the GRADE methodology where the quality of the evidence was rated as
high, moderate, or low depending on the likelihood further research would change their
recommendations (Mitchell et al., 2013). Using the GRADE methodology, the work
group formulated their recommendations based on the overall review of the evidence. An
overall rating of the literature was not provided, however guideline grades were provided
for each individual reference cited.
The guideline Adult Depression in Primary Care provided many
recommendations including screening, diagnosis, treatment options, and follow-up care
for those with depression. Mitchell et al. (2013) supported the use of the Patient Health
Questionaire-9 (PHQ-9) by presenting meta-analyses, systematic reviews, and many
references they graded as low-level evidence. In addition to the use of the PHQ-9, the
authors recommended further assessment of the patient to include past medical history,
co-morbidities, substance use, and the safety of the patient and others, supported by a
multitude of evidence ranging in meta-analyses, references graded as high-evidence,
systematic reviews, and what the work group deemed as low-quality evidence.
Recommendations for cultural considerations, special populations (geriatrics, patients
with cognitive impairment, and perinatal patients), had the same variety of evidence
levels as other recommendations presented, ranging from high-evidence, to specific types
of studies like meta-analysis and systematic reviews, and also included low-quality
evidence. For the diagnosis of depression the criteria from the DSM-IV and the
American Psychiatric Association Guideline were outlined within this guideline and
included to discuss evidence-based treatment and follow-up plans.
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Overall, the recommendations were appropriate for the supporting evidence. The
authors of the guideline provided an extremely comprehensive review and synthesis of
literature. Each individual recommendation had the foundation of sound evidence, and a
provider could rely on the recommendations of this guideline. Lastly, the procedure for
updating the guideline was specifically explained. Mitchell et al. (2013) explained
revisions occurred every 12-24 months dependent on changes within the literature and
practice. Each of the work group members remained current on the literature by
reviewing peer-reviewed journals and meeting with the work group during and at the end
of the guideline cycle (Mitchell et al., 2013). With each revision, the guideline must be
approved by the ICSI Committee on Evidence-Based Practice, which was comprised of
medical providers and nurses representing the ICSI member organizations within the
United States (Mitchell et al., 2013).
Clarity and Presentation
In Adult Depression in Primary Care (Mitchell et al., 2013), the key
recommendations were easily identified within the algorithm and were available to assist
providers in the screening, diagnosis, treatment, and follow-up for patients with
depression. These recommendations included the use of the PHQ-9 or other identified
screening tools when patients were suspected or presented with depressive symptoms
(Tragel et al., 2013). Tragel et al., (2013) also specifically detailed the DSM-IV criteria
for diagnosing depression, as well as guided providers in the clinical interview to include
history of present illness, co-morbidities, substance abuse, and current medications. It
was then recommended the clinician assess if the patient diagnosed with depression is
unsafe to themselves or to others (Tragel et al., 2013).
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The guideline recommended utilizing patients’ PHQ-9 score to assist with
potential treatment options, as shown in the table below.
PHQ-9 Score

Depression Severity

5-9

Mild Depressive Symptoms

Treatment
Recommendations






10 -14

Mild Major Depression






15-19

Moderate Depression




Scores ≥ 20

Severe Major Depression




Exercise
Behavioral
activation
Call provider if
symptoms worsen.
No improvement in
1-2 months, contact
mental health
provider.
Above
interventions
Begin
pharmacotherapy or
psychotherapy
Weekly contact
initially, decreased
to monthly followup
Above
interventions
Weekly contacts,
bi-monthly followups, then finally
reduced to monthly
Above
interventions
Weekly follow-ups
until symptoms
lessen in severity

Table 1. Depression treatment recommendations (Mitchell et al., 2013)
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The above recommendations are specific and unambiguous. The specificity of the
recommendations can be shown in the recommendation for diagnosing depression with
the use of the clinical interview. Mitchell et al. (2013) provided the detailed explanation
of the DSM-IV criteria required for a diagnosis of depression. They also provided to a
mnemonic SIGECAPS to help providers remember the symptoms of depression, which
include sleep disorder, interest deficit, guilt, energy deficit, concentration deficit, appetite
disorder, psychomotor retardation or agitation, and suicidality. The authors also
provided explanation of differential diagnoses such as anxiety or somatoform disorder,
adjustment disorder, and bipolar disorder.
The variety of treatment options were explained in detail as well as a comparison
of psychotherapy versus pharmacotherapy. Mitchell et al. (2013) provided evidence to
support the use of various psychotherapies including cognitive behavioral therapy,
interpersonal therapy, short-term psychodynamic psychotherapy, and problem-solving
treatment. Complementary and alternative therapy including acupuncture and herbals
were also discussed within the guideline. In regards to pharmacotherapy, the use of
selective serotonin reuptake inhibitors as the first-line treatment was discussed. Alternate
pharmacotherapy options included the use of secondary amine tricyclics, monoamine
oxidase inhibitors, and atypical antipsychotics. The guideline stressed the importance of
choosing the right medication depending on the patient’s response to previous treatment,
patient preferences, medication side effects, availability, costs, drug-drug interactions,
and safety. Proper administration of pharmacotherapy along with potential side effects
was also discussed in detail.
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Application
When discussing potential organizational barriers, Mitchell et al. (2013) discussed
barriers ranging from implementing a screening program to the potential barriers in the
patient’s care. For caring for the patient with depression, the first recommendation was
to assess the current organizational culture in regards to depression screening and
treatment. This assessment included the evaluation of a need for a shift in the
organizations beliefs, values, and behaviors (Mitchell et al., 2013). Other potential
barriers listed included the necessity of training staff, the implementation of the
recommended collaborative care model, and creation of patient education and self-care
management materials (Mitchell et al., 2013). With the recommendation of the
collaborative care model, which encouraged the use of a mental health specialist, this
may present a barrier such as in rural areas where mental health specialists may be scarce
(Mitchell et al., 2013). To assist in overcoming potential barriers and provide educational
resources, the authors of the guideline provided a variety of resources and tools that
addressed comorbidities, cultural considerations, drug interactions, electroconvulsive
therapy, professional organization resources, governmental resources such as databases,
and perinatal resources (Mitchell et al., 2013).
The authors of the guideline also briefly discussed potential cost implications of
applying the recommendations included in the guideline. The discussion of cost
implications focused on the implementation of a collaborative care model. Mitchell et
al., (2013) provided evidence that suggested an increased cost to the care system for the
first year, but a potential turn in cost in the second year. The authors list the only longterm study, the IMPACT study, which showed a cost savings of $3,363 per patient over
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the four year period (Unutzer, 2008).
Editorial Independence
ICSI provided an explicit statement stating the organization did not influence the
guideline development. The statement acknowledged the work group was not paid by the
organization and all the recommendations were based on the independent evaluation of
the evidence by the work group (Mitchell et al., 2013). Conflicts of interest were also
specifically listed. Mitchell et al., (2013) shared every work group member along with
the presence or absence of potential conflicts of interest. For each work group
participant, the conflict of interest section specifically listed job titles, department,
affiliated organizations; local, regional, and national committee affiliations; guideline
related activities; research grants; and finally financial and non-financial conflicts of
interest. Those with potential financial conflicts of interest specified an estimated dollar
amount. Of the nine work group members, only one listed financial and non-financial
conflicts of interest which included being a lecturer for the University of Minnesota, and
stock holdings with two pharmaceutical companies.
Comparison of Other Guidelines
Other depression screening guidelines that are available include the Veteran
Affairs and Department of Defense clinical practice guideline for management of major
depressive disorder (2009) and the American Psychiatric Association (APA) guideline
Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2013).
The Department of Veterans Affairs (VA) and Department of Defense (DOD) created a
guideline related to the screening, diagnosis, and treatment of major depression. Their
explanation of the method used to retrieve evidence is more detailed in the use of a
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PICOT question, provided a list of the databases that were searched, as well as a more
detailed inclusion criteria. The Department of Veteran Affairs inclusion criteria were
English studies performed in the U.S., United Kingdom, Europe, Australia, Japan, and
New Zealand (Department of Veteran Affairs, Department of Defense, 2009). The
evidence provided from the literature review was also rated by the strength of evidence,
the scheme used was provided.
The American Psychiatric Association (APA) published the third edition of their
guideline Practice Guideline for the Treatment of Patients with Major Depressive
Disorder in 2010. This guideline was revised by an APA work group that reviewed
literature published after the year 2000, which allowed the work group to review
literature published after the second edition of this guideline. The work group created
evidence tables with the current literature to evaluate its strength. Recommendations
made in this guideline underwent both internal and external work group peer review.
Overall, the recommendations are very similar between the Department of
Veteran Affairs and Department of Defense guideline and the APA guideline when
compared with the ICSI guideline. The Department of Veteran Affairs and Department
of Defense guideline also recommended the use of the PHQ-9 (2009), whereas the APA
guideline did not specifically recommend one screening tool over another. The VA/DOD
guideline also evaluated the evidence in regards to different populations such as the
elderly and post-partum women (2009). Recommendations were also made for a detailed
evaluation that included history of present illness, comorbidities, the current use of
medications, and substance abuse (VA/DOD, 2009). As with the ICSI guideline, the
VA/DOD explained the symptoms of differential diagnoses which include bipolar
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disorder, substance use disorder, depression not otherwise specified, and dysthymia
(2009). The Department of Veteran Affairs and Department of Defense and the APA
guideline recommended and explained very similar treatment options as ICSI; which
included detailed explanation of psychotherapy and pharmacotherapy. Also included in
the VA/DOD guideline is a more detailed discussion of self-management strategies
which include nutrition, exercise, sleep hygiene, tobacco use, caffeine use, alcohol use
and abuse, and pleasurable activities (2009). One topic the VA/DOD addressed that the
ICSI guideline did not, is that of psychosocial issues including housing, finances,
problematic relationships, social support, spiritual issues, occupational problems,
difficulties with activities of daily living, and other potential stressors (2009). The APA
guideline also coincided with the ICIS guideline by stressing the importance of a
collaborative effort in regards to the treatment of a patient with depression.
Although the three guidelines addressed were very similar, the ICSI guideline
might be considered superior due to the recommendations guided specifically to primary
care, and the use of the screening and treatment algorithm. Algorithms allow for
providers to have a simple and fast guide in assessing and diagnosing depression.
Algorithms may also help the provider quickly remember steps that may have otherwise
been forgotten or skipped. The presentation of the ICSI guideline along with the
foundation of evidence allows for providers to have confidence in this guideline and its
recommendations. The ICSI guideline also is focused on primary care and encourages
the use of collaborate efforts in regards of the patient.
This author recommends the utilization of this guideline by nurse practitioners
due to the ease of the screening and treatment algorithm and foundation of guideline as
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evidence-based. Recommendations for this guideline could also be made to the
investment and resources ICSI has in the revision process of the guideline. Providers can
be confident this guideline has more current evidence in comparison to the older
VA/DOD guideline whose last updated version was released in 2009. Guidelines such as
ICSI enables a more efficient transition of evidence from research to practice, enhancing
the care provided by nurse practitioners and other healthcare providers
Conclusion
In the primary care setting, the knowledge foundation a provider must maintain is
extremely large. The use of guidelines and recommendations facilitates the nurse
practitioner and other providers to provide the most up to date care to their patients as
possible. However many guidelines and recommendations are available and providers
must be able to quickly analyze the quality of the guideline as well as the organization or
group that is providing the recommendations. Based on the above analysis, this author
recommends the use of the guideline Adult Depression in Primary Care, as the most
current and most appropriate for the use of depression screening and treatment in the
primary care setting.
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Depression Screening in Primary Care: A Practice Inquiry Project
Depression knows no boundary and is estimated to affect 350 million people
worldwide and is the leading cause of disability (WHO, 2012). The Center for Disease
Control (CDC) reported 8% of the U.S. population age 12 years or older report current
depression (2012). The American College Health Association (ACHA) has performed the
National College Health Assessment twice each year. In the spring of 2013, the ACHA
released the results of data on 123,078 participants aging 18 years and older. Of these
participants, 45% (n=55,385) stated they “felt things were hopeless”, 55% (n=67,747) “felt
very lonely”, and 31.3% (n=38,523) “felt so depressed it was difficult to function”. The
ultimate cost of depression is that of a person’s life. In 2004 the CDC ranked suicide as the
11th leading cause of death in adults 18 years and older (CDC, 2012). The American
College Health Association (2013) found among college students in the last 12 months,
7.4% (n=9,107) seriously considered suicide, 5.9% (n=7,261) intentionally cut, burned,
bruised, or otherwise injured themselves, and 1.5% (n=1,846) attempted suicide (Table 1).
Depression in College Age Students
In the last 12 months
National College
UK 2013
Health Assessment
Health
(2013)
Behavior Study
(J. Brown, personal
communication, April
30, 2013)

Considered Suicide
7.4%
Made A Plan
(no data available)
Attempted Suicide
1.5%
Intentionally Harmed
5.9%
Table 1. Depression in College Age Students

7.7%
5%
0.9%
5.7%

LGBT Statistics
at UK
(J. Brown, personal
communication, April 30,
2013)

24%
27%
6%
19.4%

In 2013, the University of Kentucky conducted a Health Behavior study focusing
on stress and coping behaviors among 151 college students, 17 years or older; statistics
related to suicide ideation and self-injury at the University of Kentucky were very similar
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to the national average. As seen above in Table 1, the statistics were significantly higher in
those students who identified on the lesbian, gay, bisexual, transgender (LGBT) spectrum.
Unfortunately, the ACHA National College Health Assessment did not further stratify the
results into students identifying on the LGBT spectrum. The rates of students struggling
with depression and thoughts of harming themselves, should compel providers to provide
depression screening and treatment among college age students.
Screening for depression in primary care has been supported by the World Health
Organization, the U.S. Preventive Services Task Force, and the American Academy of
Family Physicians (AAFP). The AAFP and U.S. Preventive Task Force both recommend
in clinics with the capability to treat depression, adults 18 years and older should be
screened for depression at every visit. The Institute for Clinical Systems Improvement
developed a guideline titled Adult Depression in Primary Care (Mitchell et al., 2013) to
assist providers in the assessment, diagnosis, and treatment of depression.
Despite these statistics and guidelines, many providers struggle to implement
depression screening. A literature review found many validated screening tools are
available but the primary barrier to depression screening was the limited resources
available to providers, limited time providers have for appointment times, number of
trained staff available to perform screening, and the variety of depression screening tools.
It has been shown depression screening does increase the duration of office visits by an
average of 6 minutes if a depression screening tool was administered by a nurse and scored
by a physician (Schmitt, Miller, Harrison, & Touchet, 2010).
To overcome this particular barrier, studies have been performed to look at the use
of different technologies for screening, such as a computer-based approach, or on the sign-
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in forms for the patients to allow for faster screening (Farrell et al., 2009; Fann et al.,
2009). Fann et al. (2009) utilized electronic registration to screen patients for depression.
Initially, the patients were quickly screened using the PHQ-2, if either question was
answered positively, the following seven questions of the PHQ-9 would be triggered. The
average reported time to complete the PHQ-9 screening was two minutes (compared to six
minutes found by Schmitt, Miller, Harrison, & Touchet). The guideline, Adult Depression
in Primary Care, further recommends screening for depression via the PHQ-9, and further
assists providers to efficiently provide further evaluation and treatment to continue to
decrease patient appointment times (Mitchell et al., 2013).
Evidence from the literature raises multiple questions: how often do providers
currently screen for depression?, will electronic screening tools at intake improve attention
to and documentation of depression screening by clinicians?, and would education
provided to clinicians about depression screening and available resources improve attention
and documentation to depression screening? Thus the purpose of this study was to answer
these questions by evaluating the implementation of a depression screening program at a
large public university student health clinic utilizing patient charts and a provider survey.
The objectives of this study were as follows:


To evaluate the current frequency with which providers perform and document
depression screening.



To determine the potential effect of education on the clinic’s providers’ attention to
and documenation of depression screening.



To determine the potential effect a pre-administered PHQ-9 may have on providers’
attention to and the documentation of depression screening.
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Theoretical Framework
To assist with the evaluation of the implementation of depression screening at a
large university’s student health clinic, the Model for Evidence-Based Practice Change
(Larrabee, 2004; & Ciliska et al., 2011) was utilized. The Model for Evidence-Based
Practice Change is composed of six steps used to discuss the process of implementing and
evaluating the depression screening program. The first step requires the assessment for a
need for practice change. This assessment was performed prior to the implementation of
this study through chart reviews performed previously (by others not involved in this study)
and clinician statements regarding the need and support of depression screening. The
second step in this model requires the review of the best and most current evidence. The
review of literature supporting this study consisted of reviewing successful depression
screening programs at another large, public university; reviewed evidence supporting
depression screening tools; the evidence supporting national recommendations regarding
depression screening; and finally, literature addressing barriers to depression screening.
The third and fourth steps of the Model for Evidence-Based Practice Change
(Larrabee, 2004; Ciliska et al., 2011) consisted of analyzing the evidence and designing the
practice change. The planning of the practice change consisted of three parts. The first
part of the planned practice change was to evaluate the current depression screening rates at
a large university health clinic, which was performed by performing an initial retrospective
chart review. The second part of the practice change consisted of a provider educational
session regarding current depression screening rates and the planned initiation of
depression screening within the clinic. The final component consisted of the actual
implementation of the PHQ-9 screening tool within the clinic. The evidence from the
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literature supported the use of the PHQ-9 depression screening tool in an electronic-sign in
format (Mitchell et al., 2013; Fann et al, 2009).
The fifth step was the focus of this study which included the implementation and
evaluation of the change in practice (Larrabee, 2004; Ciliska et al., 2011). Ciliska et al
(2011) describes the smaller components of step five to include the evaluation of the postpilot data and verbal feedback from providers to decide if the practice change will be
adapted, adopted, or rejected. The sixth and final step of the model, integrating and
maintaining the change, would be completed by the clinic after the evaluation and
recommendations regarding the practice change have been made at the conclusion of this
study.
Design
This study consisted of a quasi-experiemental, pre-post intervention design that was
performed in three parts. Initially, a retrospectice chart review was performed to evalaute
the current frequency of depression screening at a large university health clinic in the fall of
2014. During the winter break between semesters, a 25 minute provider educational
session during a provider monthly meeting, was conducted to review the results of the
initial chart review, discuss national depression screening recommendations, and to inform
providers about the planned pilot of a depression screening program utilizing the PHQ-9
within the electronic patient sign-in form. After this educational session, providers were
asked to answer a brief survey regarding the usefulness of the educational session, if the
educational session might be useful in changing their current screening practices, and
finally to include the two largest barriers they see to screening within the clinic. Finally,
the third component of the study included a final chart review, performed during the Spring
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of 2015. This chart review attempted to evaluate potential changes in provider’s
performance and documentation of depression screening.
Setting and Study Population
The university health clinic was located on a large university campus and provided
health services to all full-time students of the university and part-time students who paid
the health fee or paid on a fee-for-service basis. This clinic provided services such as
behavioral, general, and women’s health. The clinic was staffed by physicians, nurse
practitioners, registered nurses, nursing care technicians, a dietician, and two health
educators. The university also had behavioral health and counseling services available for
students.
The study consisted of two convenience samples, 1) electronic medical records of
patients age 18 and older and 2) providers at a large university health clinic. The clinic
appointments consisted of patients for both acute and wellness visits. To be included in the
study the patient must have been 18 years or older, and had completed the annual medical
history form at the time of sign-in. The annual medical history form is automatically
generated for patients to fill-out when seen in the clinic every 365 days. This form allows
the patients to review and updated their medical history, current medications, social history,
and etcetera. Patient charts were excluded from the study if patients were younger than 18
years or had not completed the annual medical history form at the time of their visit.
Providers were invited to participate in the study at the educational session. Fifteen
providers completed the informed consent forms as well as completed the anonymous
paper survey provided at the end of the session.
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Method
Initial Retrospective Chart Review
After receiving approval from the Institutional Review Board (IRB), the initial
retrospective chart review was performed by systematically reviewing 116 medical records
of patients meeting the inclusion/exclusion criteria. Within a two week period,
approximately 500 patients were seen at the clinic that were required to complete the
annual medical history form. For a quality improvement study such as this, with a
population size of 400-500 the World Health Organization recommended a sample size of
116 patient charts (Agins, Seung, & Heiby, 2008). For the initial chart review, to achieve a
sample size of 116 patient charts, the principle investigator pulled every fourth chart for
patients seen that had completed the annual medical history form between November 1021, 2014.
Provider Educational Session
A 25 minute educational session was conducted during a monthly provider meeting
on February 12, 2015, after the initial chart review and before the initiation of the PHQ-9
screening on the electronic sign-in form. The presentation included a brief didactic portion
followed by discussion with the providers to address any comments or concerns regarding
the screening program. The purpose of this educational session was to educate providers
regarding the current depression screening practices, the PHQ-9 screening tool and its
implementation on the electronic intake form, depression treatment options, campus
resources available for students with depression, and depression screening practices at other
universities. At the end of the session, providers were asked to anonymously complete a
brief survey evaluating the effectiveness of the session (Appendix C). At the time of the

51

study, 15 physicians and nurse practitioners were employed in primary care at the clinic.
Only providers employed by the university health clinic were recruited and included in this
survey. Exclusion criteria included other employees of the clinic such as office staff,
certified medical assistants, and nurses.
Post-intervention Chart Review
After the initial retrospective chart review and provider educational session, the
health clinic created a depression screening template utilizing the Patient Health
Questionnaire-9 (PHQ-9), consisting of nine questions that have shown to be effective in
screening for depression (Kroenke, Spitzer, & Williams, 2001), and the use of the PHQ-9 is
recommended by the guideline, Adult Depression in Primary Care (Mitchell et al., 2013).
The university clinic had the unique ability to create templates within their
electronic medical record on the clinician side (without having to utilize technical support).
Originally, the PHQ-9 template was planned to included as a part of each patient’s annual
medical history form, requiring the patients to be screened once each year. However, prior
to implementation the clinic opted to implement the screening template to generate every
90 days a patient was seen in the clinic. The clinic providers thought that the depression
screening frequency should be increased, but yet desired a smaller proportion of students
screened as the practice change was implemented.
The screening template began by quickly screening patients using the PHQ-2,
consisting of the first two questions of the PHQ-9: “in the past two weeks how often have
you been bothered by any of the following problems? 1) little interest or pleasure in doing
things, 2) Feeling down, depressed, or hopeless” (Kroenke, Spitzer, & Williams, 2001).
For each question, students selected an answer ranging from 1) not at all, 2) several days,
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3) more than half the days, or 4) nearly every day. A positive screen (a score of 4 or more)
occurred if the patient answered more than half the days or nearly every day to either
question. A postive screen resulted in asking the patient to answer the remaing seven
questions of the PHQ-9. Each answer of the PHQ-9 has a weighted score that totaled
allowed the healthcare provider to quantify the depressive symptoms in terms of transient
(score of 1-4), mild (score of 5-10), moderate (score 10-19), or severe depression (scores ≥
20).
After the patient completed the PHQ-2 or PHQ-9 the template automatically totaled
the weighted respones, and the template with the total screening score was immediately
sent electronically to the patient’s provider to review while the patient was being placed
into the exam room. If the patient had a screening score of 4 or greater, the provider could
discuss the score with patients, print an educational handout, and send the patient one of
two secure e-mail messages further discussing the depression screening score, severity of
score, recommendations for further evaluation, and campus resources available to the
student (Appendix A and B).
The depression screening template was initiated on Februray 16, 2015. A second
chart review was performed utilizing the same procedure as the intital chart review. This
second chart review evaluted charts of patient seen between the dates of February 16-27,
2015. Due to several factors discussed later in the limitations section of this paper,
including the discontinuation of the pilot screening tool two days early, a smaller sample
size (n=97) was utilized. Both chart reviews gathered data including the date of visit,
gender, age, current diagnosis of depression, current treatment for depression, if depression
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screening was documented, the tool used for screening, depression screening score, and if
treatment or an intervention was provided.
Results
Pre-intervention Chart Review
Of the 116 charts reviewed 33.6% (n=39) were male and 66.4% (n=77) were
female patients, with ages ranging from 18 to 34 years old and a mean age of 20.5 years.
Upon reviewing the patient charts, 11% (n=15) patients listed a history of depression with
4.4% (n=6) listing a current medication for the treatment of depression, and 0.7% (n=1)
documenting current treatment of depressoin with counseling. Despite the above,
depression screening was not documented for any patient.
Educational Session Survey
Results of the anonymous provider survey which evaluted the educational session may be
seen below in Table 2.
Depression Educational Session Survey Results (n=15)
Results by individual question Strongly Disagree Neutral
Disagree
15.8%
The educational session
(n=3)
provided new information
regarding depression
screening tools.
33.3%
The educational program
(n=5)
provided new information
regarding depression
screening programs at other
uniersity health clinics.
13.3%
I found the educational
(n=2)
program to be beneficial.
26.7%
The educational program
(n=4)
increased awareness of
current depression screening
practices here at the
univserity health clinic.
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Agree
42.1%
(n=8)

Strongly
Agree
26.7%
(n=4)

40%
(n=6)

26.7
(n=4)

53.3
(n=8)
40%
(n=6)

33.3
(n=5)
33.3
(n=5)

13.3%
The information received
(n=2)
from the educational program
made me think about the way
I practice.
6.7%
The infromation motivated
(n=1)
me to screen patients for
depression.
6.7%
6.7%
How often did you think you
(n=1)
(n=1)
were providing depression
screening for patients?
Table 2. Depression Educational Session Survey Results

33.3%
(n=5)

40%
(n=6)

13.3
(n=2)

13.3%
(n=2)

53.3%
(n=8)

226.7%
(n=4)

26.7%
(n-4)

33.3%
(n=5)

26.7%
(n=4)

Perceived screening barriers. At the end of the survey, providers were asked to
list two factors that are currently impeding depression screening at the university health
clinic. These questions were open ended with 52.6% of the providers responding (n=10)
that limited time for screening was the major factor hindering depression screening at the
health clinic. Other responses included fear of liability of the provider (10.5%, n=2),
limited resources (10.5%, n=2), no screening tool in place (15.8%, n=3), lack of awareness
regarding the need for screening (5.3%, n=1), and limited clinician availability (5.3%,
n=1). Based on the two most common barrier responses (limited time and lack of
screening tool), the intervention was tailored to provide a valid, time efficient screening
template utilizing the PHQ-2 and PHQ-9.
Post-intervention Chart Review
The post-intervention chart review resulted in a sample size of 97 patients. Table 3
provides a comparison of the patient demographics and screening results of the initial
retrospective and post intervention chart reviews. The primary investigator did not stratify
the demographics beyond age and gender.

Charts reviewed

Pre-Intervention Review

Post-Intervention Review

116

97
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Gender
Male
Female

33.6% (n=39)
66.4% (n=77)

37.1% (n=36)
62.9% (n=61)

Age

18-34, mean of 20.4

18-47, mean of 21.6

Hx of depression
listed

11% (n=15)

6.2% (n=6)

4.4% (n=6)
0.7% (n=1)

2.1% (n=1)

0%

60.8% (n=59)

Current Treatment
Medication
Counseling
Screening
Documented

Table 3. Pre and Post Chart Review Results Comparison
With the initiation of the PHQ-9 screening, 60.8% (n=59) charts had depression screening
with the PHQ-9 documented. Of the charts documenting depression screening 6.7% (n=4)
patients had a postive depression screening with scores of 4, 6, 7, and 15. For the patients
with a postive screen, all four charts (100%) had documentation of discussion regarding the
depression screening score and interventions provided. Three (75%) of the four patient
charts received the first secure e-mailed message (Appendix A) discussing the depression
score, symptoms of depression, the potential need for further evaluation, and campus
resources available for treatment. One (25%) of the four patient charts received the second
secure-email message (Appendix B) discussing the same information as the first letter,
however containing more strongly worded discussion regarding suicidal thoughts and the
need to seek immediate attention. The secure e-mail messages were automatically sent to
patients the day after the visit, and depended on the severity of their scores. The messages
were also included in the electronic medical record as documented coorespondence
between the provider and the patient.

56

Although not shown in the results of this study, verbal feedback from providers and
campus resources expressed concern regarding a perceived marked increase in students
receiving postive depression screens requiring further evaluation. Campus resources and
the student health clinic expressed concern regarding the increased demand and the limited
availability of appointment times and providers for further evaluation. Due to these
expressed concerns, the depression screening period was ended two days early on
Thursday, Februrary 26, 2015. Due to the screening tool being stopped, 39.2% (n=38) of
the charts did not have depression screening documented, which all 38 visits occurred on
the last two days of the planned two week pilot period. Had the screening tool been
continued, depression screening would have been documented on 100% of the charts
reviewed. Although the screening tool had been stopped, the two dates were included into
the study due to the parameters of IRB approval based on the number of days of the study.
When evaluating the potential effect of implementing the PHQ-9 screening tool, the
chi-square test was utilized showing a significant association (<0.01) between the
implementation of the PHQ-9 tool and the documentation of depression screening. It was
noteworthy the charts reviewed of patients in the post-intervention review without
documented depression screening occurred on days when the PHQ-9 screening tool was
not being used throughout the clinic (discussed further in the limitations section of this
paper). A second chi-square test was utilized to showing a significant association (<0.01)
between the lack of the PHQ-9 screening tool and no documentation of depression
screening.
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Discussion
Overall, the intervention was effective in increasing the rates of depression
screening at the university health clinic. Initially, when presented to the providers during
the educational session, the results of the initial retrospective chart review did not surprise
the providers at the university health clinic. Previous reviews had been performed with
similar results, however using this knowledge and the Model for Evidence-Based Practice
Change efforts were made to assist the health clinic in making a sustainable change.
Similar to barriers listed in the literature review, in the survey providers listed limited time
for depression screening as the primary barrier, while a second barrier listed was the lack of
a screening tool available. This study attempted to assist the providers at the university
health clinic in overcoming both of these barriers.
In 2011, Klein, Ciotoli, and Chung performed a similar study at a large urban
university health clinic. The authors also utilized an electronic PHQ-2 initial screening
with positive scores resulting in the continuation of the PHQ-9. As a retrospective chart
review, the authors found a 6% depression rate (similar of those nationally), with less than
1% of those patients scoring greater than 20 with severe depressive symptoms. Within the
study, clinicans were able to refer to campus resources and reported no additional strain on
the resources infrastructure, however the results showed only 35.7% of the patients with
positive screens received any type of intervention.
During the planning phase of the implementation of the depression screening
program, verbal feedback from providers at the university health clinic, behavioral health,
and campus counseling services were sought and valued. Initially, the electronic
depression screening tool was planned to be used for students completing the annual health
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history form. The orginial annual screening frequency was thought to slowly introduce a
practice change without burdening the campus resources such as behavioral health and the
on campus counseling center.
As described above, the depression screening template began with the PHQ-2, and
patients with a positive screen were asked to complete the remaining seven questions of the
PHQ-9. At the conclusion of the screening, the template automatically computed the
patient’s depression screening score based on their responses to the PHQ-2 or PHQ-9.
Providers were then able to review the scores prior to seeing the patient, and had the ability
to discuss the scores, and provide a treatment or intervention as deemed necessary.
Although this process required a slight practice change for the providers, the intention was
to create a screening tool that was placed within the current workflow of the clinic reducing
the additional efforts of the provider to screen and compute scores. The use of the
electronic sign-in form was also an attempt to limit the amount of time required for
screening, as previous studies demonstrated a varying time of two to minutes to screen
electronically (Fann et al., 2009) compared to the six minutes to screen utilizing various
methods of paper or staff-assisted screening tools found by Schmitt, Miller, Harrison, &
Touchet (2010). This study did not specifically evaluate the time spent by patients or
providers screening and addressing scores, as the retrospective chart review design did not
allow for time measurement.
Not only was the time used to screen a patient for depression a voiced concern, but
additional time required to discuss depression screening scores, treatment, and
interventions was also discussed. In an attempt to reduce the necessary time, the health
clinic created a depression screening handout that could be printed at the time of the visit,
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as well as two different letters that could be securely emailed to the patient the day after a
positive screen. As discussed earlier, the first letter (Appendix A) was created for patients
with mild to moderate depression scores (scores between five and nine). This letter
discussed symptoms of depression, campus and community resources, and addressed
suicidal ideation. The second letter (Appendix B), was designed for scores suggesting
moderate to severe depression (scores greater than 10), which presented the same
information as the first letter, but was more strongly worded to stress the need for further
evaluation. Again, actual time reduction with the use of the depression screening handout
or e-mails was not able to be gathered by utilizing the chart review design of this study, and
remains an area for further study. The clinic stakeholder and primary investigator created
these documents in an effort to guide and provide the provider and patient with
supplemental materials to ease the transition of the intervention.
Comparing the pre-intervention and post-intervention depression screening
frequencies, there was a statisitcally significant increase in depression screening after the
PHQ-9 screening tool was implemented. The screening tool was piloted for a two week
period from February 16 to Februrary 27, 2015. However as discussed previously due to
increased concern regarding limited the availablility of resources, the screening tool was
ended two days earlier than planned. This study provided only four positive screens of the
patients completing the annual health history form. However, with the clinic’s decision to
change the screening frequency from using the annual health history from to screening
every 90 days, the new template automatially screened every patient seen at the university
health clinic in that two week period. Anecdotally, the clinic providers voiced concerns of
much higher postive screening rates (greater than 20% postive screens) than shown in the
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results of this study. The difference in the positive screening rates occurred due to the
continued use of the annual health history form as the inclusion criteria for the study. The
annual health history form was continued to be used to provide a more detailed picture of
the patient population and to remain consistent with patient selection and remain compliant
with the IRB approved chart selection methods. Further studies could be performed to
assess the postive depression screening scores of the all patients seen at the clinic during
the pilot time period. Also, studies could attempt to look further into college majors, class
(freshman, sophmore, junior, senior, graduate student), and sexual orientation. Due to the
results of the UK 2013 Health Behavior survey, further evaluation of depression and sexual
orientation would be beneficial.
The two dates that the screening tool was on hold were included in this study
originally to evaluate potential changes in depression screening if no tool was active within
the workflow of the provider. Interestingly, although depression screening was a hot topic
of discussion surrounding the implementation of the screening program, upon the
discontinuation of the screening tool, it was noted by the primary investigator that of the
charts reviewed for February 26-28, 2015, no depression screening was documented. The
difference in depresison screening while the tool was operational versus when the tool was
discontinued was statistically significant. This supports the need for a simple tool that may
be seemlessly incorporated into the provider’s workflow to assist in screening patients for
depression.
However, this also supports a larger issue: resource utilization. The primary reason
the screening tool was stopped, was due to the concern of the demand the number of
postive depression screens placed on campus resources. Both the behavioral health and the
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campus counseling center quickly filled all appointment times, with the next available
appointments stretching into a two to three week window. The decreased appointment
availability created concern regarding the ability to further evaluate and treat students in a
timely and appropriate manner.
Studies reviewing depression screening have shown the importance of only
providing depression screening when staff-supported resources are in place to allow for
further evaluation, treatment, and follow-up (O’Connor, Whitlock, Gaynes, & Beil, 2009;
Gilbody, House, & Sheldon, 2009), while the USPTF recommendation statement
categorizes depression screening with support a Grade B, however without support the
recommendation drops to a Grade C (USPTF, 2009). Although unintended, the most
important outcome of this study was the fact that regardless of thoughtful planning,
stakeholder buy-in, and the best of intentions, without the resources to further care for the
patient, screening for depression is futile and creates the potential for liability.
Limitations
One limitation to the generalizability of this study was the small sample sizes for
both the pre-intervention and post-intervention chart reviews. The post-intervention chart
review sample size was smaller than desired due to several uncontrollable factors. The first
factor lending to the smaller sample size was due to weather as classes were cancelled for
four days and the clinic was closed for a day during the two week pilot period. This limited
the patients who were on campus or who were able to be seen during the two weeks the
screening tool was operational.
Another limitation to the study was the use of the annual medical history form as
the sole template for inclusion criteria. After the initial planning period and IRB approval,
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the providers at the health clinic desired a more frequent screening than annually and opted
to use a template that automatically generated every 90 days. Although the 90-day
screening template screened every patient initially seen in that two week period, using the
annual medical history form for inclusion limited the number of charts reviewed that
potentially could have shown a greater presence of depression in the patient population.
A final limitation of the smaller sample size was the early discontinuation of the
depression screening tool. Providers at the health clinic and the campus resources voiced
concerns regarding a noticed increase in the demand of services during the screening
period. Although, not depicted in the results of this study, the health clinic made the
decision to hold the screening tool until after the results of this study were analyzed and
revisions to the practice change could be made (step 4 and 5 of the Model of EvidenceBased Practice).
Application
The results of this study may be used for this particular student health clinic to
conduct a further needs assessment to improve resources for patients with positive
depression screens. Discussions are currently being focused on improving the referral
system to behavioral health providers and the campus counseling center. Further support
staff such as social workers and additional registered nurses may be shown to be beneficial
in the further evaluation and education of patients that may receive a new diagnosis of
depression.
The study may also be applied to assist in the implementation of depression
screening in other university health services and in primary care clinics. The results of the
2013 University of Kentucky Health Behavior Study and the pre-intervention chart review
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supports the need for screening patients for depression at a university student health clinic.
However, the results of this study can more importantly be used to stress the importance of
having the necessary resources in place to provide further evaluation, treatment, and
follow-up for the patients with a positive screen as recommended by the evidence-based
practice guidelines.
Conclusion
Many university health and primary care clinics have difficulty with depression
screening. With an increased patient load and limited appointment times, many providers
are hesitant to add yet another time consuming task to the appointment. To implement a
depression screening program, clinics must be able to have a system in place to
appropriately evaluate and treat a diagnosis of depression. Clinics must also assess their
individual practice and plan a program that may be as seamless as possible within their
workflow as well as limit the amount of time required for screening. The depression
screening program described above discussed one potential program that may be utilized
by clinics for successful screening.
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Screening for depression in primary care has been supported by the World Health
Organization, the U.S. Preventive Services Task Force, and the American Academy of
Family Physicians (AAFP). The AAFP and U.S. Preventive Task Force both recommend
in clinics with the capability to treat depression, adults 18 years and older should be
screened for depression at every visit. However, many barriers inhibit the implementation
of depression screening in primary care offices such as limited time available to providers
and the lack of a depression screening program; however the largest barrier in practice is
that of limited resources.
This practice inquiry project discusses the strategy one university student health
clinic utilized in piloting a depression screening program. Manuscript one evaluated the
current literature related to the potential barriers of depression screening, available
screening tools, and attempted to review screening programs that have been successfully
implemented. Manuscript two analyzed the guideline Adult Depression in Primary Care
that was used as the foundation for the planning of the depression screening program
implemented in manuscript three. Manuscript three described the planning,
implementation, and evaluation of a depression screening program piloted at a large
university student health clinic. The findings of the project showed a significant increase in
depression screening when a depression screening tool was placed within the workflow of
the practice setting. However, the most significant findings occurred when resources had
been exhausted and the screening tool was not in place; thus providing additional evidence
to support national guidelines recommending depression screening only when the clinic has
the ability to further evaluate, treat, and provide follow-up care. Further work is necessary
to assist the clinic in maintaining the depression screening program.
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Appendix A. Depression Letter 1
Dear Student,
At your recent visit to University Health Services you completed a questionnaire about
depression during the electronic sign-in process. Based on the answers you provided, you
may be experiencing a period of mild depression.
What is Depression?
Depression is a condition in which you might feel sad, hopeless, or have a decreased
interest in activities of daily life. Everyone has times when they feel sad or blue, however
if you experience these feelings for 2 weeks or more, it may be depression.
What are the symptoms of depression?
 Irritability
 Difficulty falling asleep, staying asleep, or sleeping too much.
 Changes in appetite and weight
 Changes in energy level, usually a decreased energy, but may be periods of feeling
overexcited
 Decreased sexual desire
 Difficulty concentrating or remembering things
 Feeling hopeless
 Not caring about anything
 Unexplained physical symptoms
 Thoughts about death or suicide
*Sometimes other conditions may mimic depression; a healthcare provider can help you
find the cause for your symptoms.
How is depression diagnosed?
Your clinician or a mental health therapist can tell you if your symptoms may be related to
depression. The University of Kentucky offers several resources that may help you during
this time.
 UHS Behavioral Health Clinic may provide you with further evaluation and
treatment
o Call 323-5511 to make an appointment
UK Counseling Center: Consultation and Psychological Services
o http://www.uky.edu/StudentAffairs/Counseling/index.html
o Eligibility: Students enrolled and paying for a minimum of 6 creditbearing hours in the current semester are eligible for an Initial Assessment
which may lead to recommendations for services at UKCC and/or other
providers. (UKCC services are not extended to residents, post-doctoral
fellows, or those enrolled solely via the Employee Education Program
benefit.) For summer eligibility, please see the website or call for
information.
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o Call 859-257-8701 or go to 201 Frazee Hall to make an appointment M-F 8
a.m. - 4:30 p.m. or walk in M-F 9 a.m. - 3 p.m. to be seen same-day as
availability allows.
Other local resource in Lexington
o Comprehensive Care – 1351 Newtown Pike, Lexington, KY
 Call 859-253-2737 for an appointment

If you have a healthcare provider at home, they may also be able to offer further evaluation
and assistance.
What can you do?
 Call UHS or your regular healthcare provider if you are concerned about these
symptoms.
 If you have thoughts of hurting yourself or others call 911 immediately
o Please do not wait to talk, someone can help!
o National Suicide Prevention Lifeline 1-800-273-TALK (8255)
 Maintaining a healthy lifestyle may reduce the symptoms of depression
o Exercise at least 20 minutes every day
o Learn which activities make you feel better and do them often
o Talk to your family and friends
o Eat a healthy diet
o Limit intake of caffeine
o Get 7 to 9 hours of sleep per night
o Do not abuse alcohol or drugs
o Learn ways to lower stress, such as breathing exercises or relaxation.
Zieman, G. (2009). Depression: its symptoms and treatment. Relayhealth.
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Appendix B. Depression Letter 2
Dear Student,
At your recent visit to University Health Services you completed a questionnaire about
depression during the electronic sign-in process. Based on the answers you provided, you
may be experiencing a period of moderate or severe depression. Please call the UHS
Behavioral Health Clinic at 323-5511 as soon as possible to make an appointment for
further evaluation or go to the Good Samaritan Emergency Department at 310 S.
Limestone Street. We want to help!
What is Depression?
Depression is a condition in which you might feel sad, hopeless, or have a decreased
interest in activities of daily life. Everyone has times when they feel sad or blue. However
if you have been feeling sad or blue for 2 weeks or more, or have had a worsening in
symptoms it may be depression.
What are the symptoms of depression?
 Irritability
 Difficulty falling asleep, staying asleep, or sleeping too much.
 Changes in appetite and weight
 Changes in energy level, usually a decreased energy, but may be periods of feeling
overexcited
 Decreased sexual desire
 Difficulty concentrating or remembering things
 Feeling hopeless
 Not caring about anything
 Unexplained physical symptoms
 Thoughts about death or suicide
*Sometimes other conditions may mimic depression; a healthcare provider can help you
find the cause for your symptoms.
How is depression diagnosed?
Your clinician or a mental health therapist can tell you if your symptoms may be related to
depression. The University of Kentucky offers several resources that may help you during
this time.
 UHS Behavioral Health Clinic may provide you with further evaluation and
treatment
o Call 859-323-5511 to make an appointment
UK Counseling Center: Consultation and Psychological Services
o http://www.uky.edu/StudentAffairs/Counseling/index.html
o Eligibility: Students enrolled and paying for a minimum of 6 creditbearing hours in the current semester are eligible for an Initial Assessment
which may lead to recommendations for services at UKCC and/or other
providers. (UKCC services are not extended to residents, post-doctoral
fellows, or those enrolled solely via the Employee Education Program
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benefit.) For summer eligibility, please see the website or call for
information.
o Call 859-257-8701 or go to 201 Frazee Hall to make an appointment M-F 8
a.m. - 4:30 p.m. or walk in M-F 9 a.m. - 3 p.m. to be seen same-day as
availability allows.
Other local resource in Lexington
o Comprehensive Care – 1351 Newtown Pike, Lexington, KY
 Call 859-253-2737 for an appointment

If you have a healthcare provider at home, they may also be able to offer further evaluation
and assistance.
Please do not wait to make an appointment, call one of these resources as a soon as
possible.
What can you do?
 Call UHS or your regular healthcare provider as soon as possible for further
assistance.
 If you have thoughts of hurting yourself or others call 911 immediately
o Please do not wait to talk, someone can help!
o National Suicide Prevention Lifeline 1-800-273-TALK (8255)
 Depression may be treated in a variety of ways, your healthcare provider will be
able to help choose the best treatment for you
o Medication
o Therapy
o Natural and Alternative treatments such as massage, acupuncture, and art
or music therapies.
 Maintaining a healthy lifestyle may reduce the symptoms of depression
o Exercise at least 20 minutes every day
o Learn which activities make you feel better and do them often
o Talk to your family and friends
o Eat a healthy diet
o Do not drink a lot of caffeine
o Get 7 to 9 hours of sleep per night
o Do not abuse alcohol or drugs
o Learn ways to lower stress, such as breathing exercises or relaxation.
Zieman, G. (2009). Depression: its symptoms and treatment. Relayhealth.
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Appendix C. Provider Survey
This survey pertains to the educational session you attended regarding depression
screening. Please answer the following questions to the best of your ability.
1. The educational program provided new information regarding depression
screening tools
Strongly Disagree
Strongly Agree
1
2
3
4
5
2. The educational program provided new information regarding depression
screening programs at other university health clinics.
Strongly Disagree
Strongly Agree
1
2
3
4
5
3. I found the educational program to be beneficial.
Strongly Disagree
1
2
3
4
4.

Strongly Agree
5

The educational program increased my awareness of current depression screening
practices here at UHS
Strongly Disagree
Strongly Agree
1
2
3
4
5

5. The information received from the educational program made me think about the
way I practice.
Strongly Disagree
Strongly Agree
1
2
3
4
5
6. The information provided motivated me to screen patients for depression.
Strongly Disagree
Strongly Agree
1
2
3
4
5
7. How often did you think you were providing depression screening for patients?
Never
Every Time
1
2
3
4
5
What are 2 factors that are currently impeding depression screening at UHS?
1.
2.
Comments:
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Appendix D. Guideline Summary
The guideline, Adult Depression in Primary Care, provides detailed
recommendations regarding depression screening and implementation in primary care.
Below is a very brief overview of the recommendations made within this guideline.’
1) If depression is suspected, providers use standardized instrument such as the PHQ-9
to screen for depression. Providers should be mindful of symptomatic presentation
of depression, potential co-morbidities, and other potential risk factors.
2) Diagnosis of major depression should be done through a clinical interview utilizing
the DSM-4 criteria. The mnemonic SIGECAPS may help aid the providers’
memory of the symptoms of major depression.
3) If in place, utilize organization’s protocol to assess and minimize suicide risk and
involve mental health specialist. If no protocol is in place, it is recommended the
organization develops one.
4) Assess for substance misuse, such as alcoholism using the CAGE questionnaire if
suspected. Also assess for other psychiatric comorbidities such as bipolar disorder,
generalized anxiety disorder, or panic disorder.
5) When evaluating a patient for depression, the provider should also consider medical
comorbidities, the impact of culture and cultural differences on mental health, and
special populations such as geriatrics, dementia, and pregnant or postpartum
women
6) The collaborative care approach is recommended for patients with depression.
This includes a comprehensive treatment plan allowing the patient to share in the
decision-making process. The primary goal of treatment (rather psychotherapy,
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pharmacotherapy, or both) is for the patient to receive remission or be mostly
symptom free.
7) The guideline provides a brief table with treatment recommendations based on the
patient’s PHQ-9 score; see on next page.
Table 1. Translating Patient Health Questionnaire, 9-Item (PHQ-9) Depression Scores
into Practice based on DSM-5 Criteria
PHQ-9 Symptoms PHQ-9 Intensity
Treatment Recommendations (for
and Impairment
Severity
treatment durations, see also
Annotation #10)
1 to 4 symptoms,
5-9
Subclinical Education to call if deteriorates
minimal functional
Physical activity
impairment
Behavioral activation
If no improvement after one or more
months, consider referral to behavioral
health for evaluation
Consider for persistent depressive
disorder*
2 symptoms, #1 or
10-14
Mild
Pharmacotherapy or psychotherapy, or
#2 >0 score 2+,
Major
both
functional
Depression Education
impairment
Physical activity
Behavioral activation
Initially consider weekly contacts to
ensure adequate engagement, then at
least monthly
≥3 symptoms, #1 or 15-19
Moderate
Pharmacotherapy, psychotherapy, or
#2 >0 score 2 +,
Major
both
functional
Depression Education
impairment
Physical activity
Behavioral activation
Initially consider weekly contacts to
ensure adequate engagement, then
minimum every 2-4 weeks
≥4 symptoms,
≥20
Severe
Pharmacotherapy necessary and
question #1 or
Major
psychotherapy when patient is able to
#2 >0 score 2 +,
Depression participate
marked functional
Education
impairment, motor
Physical activity
agitation
Behavioral activation
Weekly contacts until less severe

76

8) Follow-up appointments may be utilized to help the provider assess the patient’s
response to treatment. The guideline defines remission as absence of symptoms or
a PHQ-9 score less than 5; and a response to treatment with a 50% or greater
reduction in depressive symptoms.
9) A second table provided within the guideline, assists providers in evidence-based
decisions regarding continuation and maintenance treatment duration. As seen
below.
Table 2. Depression Medication Treatment Duration Based on Episode
Episode
1st episode (major depression, single
episode)

2nd episode (major depression, recurrent)

Persistent depressive disorder or 3+
episodes or 2 episodes (major depression,
recurrent) with complicating factors such
as:
Rapid recurrent episodes
More than 60 years of age at onset of
major depression
Severe episodes or family history

Treatment Duration*
Acute phase typically lasts 6-12 weeks.
Continue psychotherapy/medication
treatment for 4-9 months once remission is
reached.
Total = approximately 6-12 months
Continue medication treatment for 3 years
once remission is reached. Withdraw
gradually.
Continue medication treatment indefinitely.

10) With each visit, it is recommended the provider evaluates the dose, duration, type,
and adherence to treatment. If unsuccessful the use of a mental health specialist
may assist in further treatment options such as such as combinations of

77

antidepressants, outpatient versus inpatient treatment, light therapy, or
electroconvulsive treatment.
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